Changing the Game

October 13 - 15, 2020

Transformation. Disruption. Innovation. Exploration. 

Just some of the many words describing how technology is constantly challenging the status quo and our perspectives.

Who are these challengers? Speakers from around the world who are “Changing the Game” – the theme this year for our flagship UBS Disruptive Technology CEO Summit event.

Join us virtually on the 13th – 15th October, across 3 days we will have

  • Live broadcast from inspiring speakers across the world 
  • Virtual exhibition and tour
  • Connect with innovative companies
+

Speakers

+

Countries

Days left

Regions


These past few years, our annual event has brought together brilliant minds to share their journey, to inspire and connect with Chairmen, CEOs, investors, entrepreneurs and market disruptors around a multitude of different tech topics.

At this year’s event, topics around the disruptive theme, medical and healthtech, biofabrics / biomaterials, cybersecurity, food disruption and other trends in technology will be featured.

Technology has the power to accomplish and do many things, and changing the world is one of them. It is a magical and revolutionary change that can help drive value for your business, investments or personal life.

Don’t miss out, join us virtually on the 13th – 15th October for a thought-provoking conversation. Stay tuned for updates around the event.


Event calendar

DTS 2020 13 Oct

Changing the Game - Asia
Time: 09:30 -12:00 HKT

DTS 2020 14 Oct

Changing the Game - Europe
Time: 14:30 -16:00 HKT

DTS 2020 15 Oct

Changing the Game - N. America
Time: 09:30 -12:00 HKT


 

Your details

I have an existing banking relationship with UBS Wealth Management

Salutation

Ex: +41232412875

Legal note
The data entered into this form is transmitted encrypted to UBS Switzerland AG via the internet and distributed to local UBS offices appropriately. Nevertheless, in order to maintain discretion, please do not include any confidential data such as account numbers. Via this form UBS does not accept any instructions for business transactions such as the opening of accounts, payment orders, trading orders, revocations of orders or authorizations, blocking of credit cards, changes of address, etc. Please contact the appropriate office or your client advisor for such transactions.

By providing your telephone number and/or e-mail address above you expressly approve UBS contacting you via telephone and/or via unsecured e-mail.

Please note: The use of e-mail can involve substantial risks such as lack of confidentiality, potential manipulation of contents or sender's address, wrong recipient, viruses etc. UBS assumes no responsibility for any loss or damage resulting from the use of e-mails. UBS recommends in particular that you do not send any sensitive information, that you do not include details of the previous message in any reply, and that you enter e-mail addresses manually every time you write an e-mail.

Confirmation

Event host

Amy Lo

Co-Head Wealth Management Asia Pacific,

UBS Global Wealth Management,

Head and Chief Executive,

UBS Hong Kong Group Managing Director

Amy Lo is Co-Head of Wealth Management Asia Pacific, Head and Chief Executive of UBS Hong Kong, and a Group Managing Director at UBS. Amy has over 30 years of experience in the banking industry. Since joining UBS in 1995, she has held a number of senior management positions including Regional Head of Ultra High Net Worth in Asia. Today, the ultra-high net worth business is the leading wealth manager for ultra-high net worth individuals in the region.

Actively involved in the development of the private banking industry in Hong Kong, Amy chairs the Executive Committee of the Hong Kong Private Wealth Management Association (PWMA), is a member of the Banking Industry Training Advisory Committee of the Hong Kong Education Bureau, and a member of the Exchange Fund Advisory Committee Financial Infrastructure Sub-Committee of Hong Kong Monetary Authority.

A passionate supporter of youth education and technological innovation in Greater China, Amy is a member of The Court and the MBA Advisory Board at The University of Hong Kong, a member of the Advisory Committee of the Department of Social Work at The Chinese University of Hong Kong, and an Advisor of the Industrial Consulting Committee at the HongKong X, a tech start-up platform aim at promotion of innovations among young entrepreneurs. She is also a Board Member of the UBS Optimus Foundation, the independent grant-making foundation that helps UBS clients improve the education and welfare of children globally.

Amy received the Executive Award at the DHL/SCMP Business Awards 2018 for her efforts in promoting the growth and development of the wealth management industry, and for her drive in building UBS as a corporate citizen in Hong Kong. She was also named by a top-tier Chinese media, China Business News, as one of the "Hong Kong Top 20 in the next 20 years" for her contribution to innovation developments in 2017.

David Chin

Head of Investment Bank Asia Pacific,

Group Managing Director,

Member of Global Investment Bank

Executive Committee

David Chin is Head of Investment Bank, Asia Pacific and China Country Head for UBS, based in Hong Kong. Between 2009 and 2015, he was Head of Investment Banking Division, Asia for UBS. Under his leadership, UBS was consistently ranked top in Asian investment banking league tables and won numerous awards.

Prior to 2009, David had held various senior positions including Head of Financial Institutions Group and Head of Mergers & Acquisitions in UBS Asia. In 2008, UBS was awarded Best FIG House in Asia by both FinanceAsia and The Asset.

He played an active role in business development for UBS, particularly in Hong Kong and China, including the development of offshore Renminbi equities and bond products since 2011; the formation of UBS Securities in China in 2007; and UBS's US$500m investment in Bank of China in 2005.

David led a wide range of capital market and M&A transactions for major clients in Asia, such as Bank of China, China Merchants Bank, China Pacific Insurance, Haitong Securities, Cinda Asset Management, and HKEx.

Between 2016 and 2019, he was a Non-executive director of Postal Savings of China. During the academic year 2015-16, he was a Visiting Bye Fellow at Selwyn College, Cambridge University, England.

David joined SG Warburg, a predecessor firm of UBS, in London in 1994, and moved to Hong Kong in 1996. He qualified as a Chartered Accountant with Price Waterhouse in London in 1993. He has a MA degree in Economics from Selwyn College, Cambridge University, England.


Speakers

Day 1 - Asia

Prof. Dean Ho

Provost’s Chair Professor

Prof. Dean Ho is Provost’s Chair Professor, Director of The N.1 Institute for Health (N.1), Director of the Institute for Digital Medicine (WisDM), and Head of the Department of Biomedical Engineering at the National University of Singapore.

Using his CURATE.AI platform, Prof. Ho has led multiple pioneering clinical studies that have validated the promise of N-of-1 medicine, where only a patient’s own data is used to personalise their treatment for the entire duration of care.

Multiple CURATE.AI-based clinical studies are ongoing or cleared for start in the areas of solid cancer and blood cancer therapy, digital therapeutics/personalised learning, and post-organ transplant immunosuppression, among others.

Prof. Ho is an elected member of the US National Academy of Inventors (NAI). Election to the NAI is the highest professional honor for academic inventors. He is also a Fellow of the American Institute of Medical and Biological Engineering (AIMBE) and Society for Laboratory Automation and Screening, as well as a Fulbright Scholar.

He is also a recipient of the NSF CAREER Award, Wallace H. Coulter Foundation Translational Research Award, and V Foundation for Cancer Research Scholar Award, among others. Prof. Ho was recently named to the Asia Tatler Gen.T List, which honours young leaders who are shaping the future of the region. Prof. Ho has appeared on the National Geographic Channel Program “Known Universe” to discuss his discoveries in drug delivery and imaging. His discoveries have been featured on CNN, The Economist, Forbes, Washington Post, NPR and other international news outlets. He has served as the President of the Board of Directors of the Society for Laboratory Automation and Screening (SLAS), a 26,000+ member global drug development organization comprised of senior executives from the pharmaceutical and medical device sectors, as well as academic thought leaders.

Aki Yuki

Co-Founder & CFO, Ory Lab

Having studied hydrodynamics in her high school days she also got awarded the YKK Special Award administered by the Ministry of Educations, Culture, Sports, Science and Technology in the 2006 High School Science and Tech Challenge (JSEC).

Having won this award she got the honor of representing Japan in the international competition, Intel International Student Science and Technology Fair (ISEF), but due to a long-term hospitalization after falling ill from tuberculosis just before the competition she was not able to participate.

She re-entered the same competition the following year and got the Grand Award of Excellence Award. In 2007 she took part in the ISEF again, although this time as a student observer. After entering the International Christian University College of Liberal Arts, she won the Bronze Medal at the Asia Science Camp of 2009 created by Nobel laureates. In 2011, although she was studying abroad in London, together with Kentarou Yoshifuji, she took part and won the Waseda Monozukuri Grand Prize, the Student Entrepreneur Championships, the Campus Venture Grand Prix and the likes with the concept of OriHime.

Graduate of the International Christian University (ICU) College of Liberal Arts, the University College London (UCL) as an exchange student majoring in Innovation Management.

Kazuhide 
Sekiyama

Director and Representative Executive Officer, Spiber Inc

Kazuhide Sekiyama, born in Tokyo in 1983, serves as Director and Representative Executive Officer of Spiber Inc. He co-founded the company in 2007 while studying Bioinformatics at Keio University.

As part of its mission to help build a sustainable society, Spiber is engaged in the development and industrialisation of Brewed Protein™, structural protein materials produced from plant-derived feedstocks through a microbial fermentation process.


Kent HO
Ching Tak

Founder and General Partner of s28 Capital, Executive Director of Sing Tao News Corporation

Kent Ho is the Founder and General Partner of s28 Capital - a San Francisco-based venture capital fund with US$170 million under management. 

The fund focuses on early stage technology companies with a strong emphasis on leveraging data to disrupt and transform traditional industries. Some of his previous investments include: Palantir, Coupang, Evernote, Plangrid, and Zoom

Kent is also an Executive Director of Sing Tao News Corporation, which maintains the highest circulation newspaper in Hong Kong as well as a presence in 4 continents.

Kent earned his M.B.A from Stanford Graduate School of Business and his B.A. from Duke University. He is an Honorary Trustee from Peking University. He also sits on multiple boards including Hong Kong Trade Development Council’s Innovation & Technology Advisory Committee, and is an independent non-executive director of Hong Kong listed Grace Wine Holdings Limited.

Kent was selected for the Young Global Leaders by World Economic Forum in 2018.

Kristine Li

Acting General Manager, Portfolio Leasing, Henderson Land Development Company Limited

Kristine Li is the Acting General Manager of Portfolio Leasing Department at Henderson Land Development.

She oversees the Group’s investment properties in Hong Kong, an overall portfolio of over 9 million square feet comprising mostly of retail and commercial and leads the launch of the group’s new “H Commerce” series of thematic commercial developments, including that of H Queen’s, the first vertical, purpose-built gallery building in Hong Kong; H Code, for leisure and lifestyle, and H Zentre for premium medical and wellness.

Li holds a Master of Science in Real Estate from The University of Hong Kong and a Bachelor of Arts degree from Stanford University, USA. Prior to joining Henderson Land, Li worked in the investment banking industry. She currently serves on the executive committee Urban Land Institute, and is a member of The Y.Elites Association, Hong Kong Pei Hua Education Foundation, and Union Hospital Charity Program Ltd.

Li is also the founder of HART, a not-for-profit art initiative under Henderson Land. HART has the mission to foster collaboration and community value through a sustainable culture of creativity and programming, including the operation of HART Haus, a studio incubator for local-based creative talents, as well as HART Foundation, which runs community-based arts education and outreach for the under-resourced in Hong Kong.

Dai Lizhong

Chairman, Sansure Biotech Inc

Dai Lizhong, graduated from Peking University. He received his doctor degree from Princeton University and completed his postdoctoral fellowship at Massachusetts Institute of Technology.

Dr. Dai is the deputy to National People's Congress, the Chinese in vitro diagnostic leader, the vice president of Hunan federation of commerce and industry,, the Chairman of Sansure Biotech Inc. In the early 20th century, the prevention and treatment of infectious disease, cancer and other major diseases in China was using backward diagnosis technology.

The high-tech diagnostic industry was monopolized by foreign companies. In order to create Chinese-own advanced technologies, Dai Lizhong resolutely give up cosy life in USA and returned to Changsha to start Sansure biotech in 2008. He led Sansure’s research team to develop a series of international creative and leading technologies, applied in disease precise prevention, diagnostics and treatment. He received more than 20 national key innovation awards, such as the second prize of national science and technology progress, National Innovation Competition Award, National Outstanding Innovation. The research team has developed more than 300 kinds of leading diagnostic and screening products for infectious disease and cancer prevention and control, maternal and child health care, nucleic acid blood screening, Outbreak prevention and control, and chronic disease management. These techniques and products fill the blank areas of domestic diagnostic industry, and promote the development of Chinese gene technology to catch up with the international advanced level. The goal is to make the complicated and expensive gene detection products become affordable and easy to use. At present, Sansure biotech has become the leading brand of Chinese molecular diagnostic industry, and is the first batch of national gene detection technology demonstration centers, National and Local Joint Engineering Research Center for Infectious Diseases and Cancer Gene Diagnosis Technology, National Intellectual Property Demonstration Enterprise.

Especially in the 2020 COVID-19 epidemic prevention and control work, Dr. Dai led the team to develop a precise, fast, simple and high-throughput novel coronavirus nucleic acid diagnostic kit. This kit has obtained more than 20 international authoritative certifications such as EU CE certification, US FDA emergency use authorization, Brazilian ANVISA registration certificate, etc., serving nearly 140 countries and regions around the world for epidemic prevention and control. The "Sansure Solution" has become the leader in COVID-19 nucleic acid testing in many countries around the world, greatly improve the nucleic acid detection capacity and detection efficiency of the epidemic.

Day 2 - Europe

Nils Wollny

CEO & Co-Founder, holoride

Nils has extensive experience in strategy, digital business and innovation. He worked as the managing director at one of Europe’s leading digital agencies before he joined Audi as Head of Digital Business. In this role, he was responsible for digital services and platforms. Nils is passionate about mobility and media and was named as one of the “40 under 40” high-potential managers by the renowned German automotive publication Automobilwoche in 2018.

That same year Nils co-founded holoride – a spin-out from Audi focusing on the next generation of in-car entertainment.

Since February 2019 Nils serves as the CEO of holoride which has been named 4x “Best of CES 2019” and acknowledged by TIME Magazine as one of “The 100 Best Inventions of 2019”.

Matteo Berlucchi

Your.MD’s Co-Founder

Matteo Berlucchi is Your.MD’s co-founder and a serial entrepreneur who has developed a knack for being first to deliver digital innovation in new consumer sectors. Prior to co-founding Your.MD he was the founder and CEO of aNobii, the world’s first ‘social ebook’ platform sold to Sainsbury’s. 

Matteo launched the first internet property website in the world, pioneered live streaming on mobile phones with Livestation and partnered with Microsoft to redefine push notifications globally with Skinkers. As a theoretical physicist, he brings scientific rigour to Your.MD’s work, as well as Italian flair.

Prof. Mark Post

Co-Founder, MosaMeat

Professor Mark Post is an MD, PhD and chair of the Physiology Department at Maastricht University. His main research interest is the engineering of tissues for medical applications and for food, which has led to the development of cultured beef from bovine skeletal muscle stem cells in an effort to supplement and transform the traditional meat production through livestock.

In August 2013, he presented the world’s first hamburger from cultured beef. He is CSO and co-founder of two companies, MosaMeat and Qorium that will commercialize cultured meat and cultured leather.


Erez
Galonska

Founder and CEO at Infarm

A self-educated farmer, entrepreneur, and inventor, Erez is founder and CEO of Infarm, the world’s fastest growing farming network.Erez spent more than a decade exploring techniques for local, sustainable agriculture in farming communities in his native Israel, Germany and the Canary Islands. This personal journey to become self-sufficient led him to found Infarm in 2013.

Today the Infarm network produces 500,000 plants a month across Asia, Europe and North America. 

Under Erez’s leadership and in collaboration with co-founders, Osnat Michaeli and Guy Galonska, Infarm has recruited an industry-leading team and developed cutting-edge R&D to help cities become self-sufficient in their food production, while significantly improving the safety, quality, and environmental footprint of food. 

In service of this vision, to date, Infarm has raised more than $100 million in funding from world leading investors.

Erez has been recognized for his forward-looking vision in multiple fora, including: Innovation Weekend Tokyo - First Prize, Vision Award Germany - First Prize as well as selection by the European Commission as one of Europe’s top innovators in the fields of agriculture and technology. In 2017 and again in 2019 Infarm became the first hydroponic farming company to receive GlobalG.A.P (Global Good Agricultural Practices) certification, one of the world’s most recognised standards for safe and sustainable food production. 

Erez resides in Berlin with his family.

Shmuel Chafets

General Partner & Vice Chairman, Target Global

Prior to joining Target Global, Shmuel was a partner at the Berlin based Hasso Plattner Ventures where he invested in companies such as iZettle and Hansoft and served as a board member in DreamLines and reBuy. Before that Shmuel was a partner at Giza Venture Capital in Tel Aviv where he invested in companies such as Soluto (sold to Asurion), Vishal.ly and other early stage internet ventures.

Together with Giza, Shmuel founded GPV, a pioneering Warsaw based venture fund where he also led virus internet and software investment. Shmuel was also co-founder of LocaLoco (sold to Say Media Group) a social gaming startup targeting emerging markets.

Shmuel started his career as strategic consultant to GCS and a consultant for several members of the Israeli parliament and government.

Tomer Weingarten

Co-founder and CEO, SentinelOne

Tomer Weingarten is a co-founder and CEO of SentinelOne. He is responsible for the company’s direction, products, and strategy. Prior to joining SentinelOne, Tomer led product development and strategy for the partially Nielsen-owned ITWP where he held the position of VP of Products after joining via the acquisition of the statistical significance based sentiment analysis and polling start up he founded.

Prior to that he held several senior application development, security and consulting roles at various enterprises, and at Carambola, the machine-learning based video ad-network where he served as the Chief Technology Officer. Tomer also serves as an advisor for security companies Javelin Networks (acquired by Symantec), SecuredTouch, Cycognito and deep learning analytics company Imubit.

Day 3 - N. America

David Rosenberg

CEO and Co-Founder, AeroFarms

David Rosenberg co-founded and leads AeroFarms, a mission-driven company that builds and operates advanced vertical farms in urban environments.

AeroFarms was listed on Fast Company’s 2019 Most Innovative Companies and Inc. Magazine’s 25 Most Disruptive Companies. AeroFarms received the inaugural Global SDG Award for Zero Hunger, was listed in Time Magazine’s 2019 Best Inventions, and received The Ethical Corporation’s 2019 Responsible Business Award in Sustainable Innovation.

As a member of the World Economic Forum, David co-chaired the Young Global Leaders Circular Economy Taskforce and is a member of the Global IoT Council. David serves as a Managing Trustee of the Liberty Science Center, a prominent U.S. interactive science museum, and is on the Board of Directors of Aspire, the world leader in cricket protein, and Clara Foods, a leader in non-animal based animal protein. David was named one of the 100 Most Intriguing Entrepreneurs at Goldman Sachs’ 2019 Annual Builders and Innovators Summit.

David received his BA from UNC Chapel Hill and holds an MBA from Columbia University.

Allen Lau

CEO and co-founder, Wattpad

Allen Lau is the CEO and co-founder of Wattpad, the global multiplatform entertainment company, where he leads the company’s vision to entertain and connect the world through stories.

A leader in Canada’s technology sector and startup ecosystem, Allen is a member of the Canadian Council of Innovators, a lobby group that advances the interests of Canadian technology companies at all levels of government. He is also the co-founder of Two Small Fish Ventures, a fund that invests in Toronto and Waterloo-based early stage internet companies with strong network effects.

Prior to Wattpad, Allen co-founded FeedM8, a mobile advertising company that was later acquired. He also previously co-founded Tira Wireless, where he helped leading brands optimize content for mobile delivery.

Allen received his Bachelor’s and Master’s degrees from the University of Toronto’s Electrical Engineering program.

Dr. Dan Widmaier

CEO & Founder, Bolt Threads

Dan has carefully tended Bolt’s growth since 2009, using his passion and expertise to lead the company through technology development, expansion, and financing.

He earned his Ph.D. in Chemistry and Chemical Biology from UC San Francisco, where his graduate research involved designing genetic circuits to control microbial organelles.


Ara Katz

Co-Founder and Co-CEO, Seed Health

Ara Katz is the Co-Founder and Co-CEO of Seed Health, a microbial sciences company pioneering the application of bacteria to impact human and planetary health.

She has worked at the intersection of technology, consumer, design, and media, and is now working with leading scientists and innovators to steward a new global standard in probiotics.

Ara previously co-founded and served as CMO of mobile commerce marketplace, Spring (backed by LVMH, sold to ShopRunner), and was on the founding team of social commerce company, BeachMint (sold to Conde Nast), where she launched six direct-to-consumer, influencer subscription brands. She is an angel investor and advisor in companies such as mindbodygreen, Stadium Goods (recently sold to FarFetch), RXDefine, women’s healthcare startup, Mahmee, and new biomaterials company, C16.

Ara has been a fellow at the MIT Media Lab’s Center for Future Storytelling and CCA’s Design MBA program, was named in Marie Claire’s “The New Guard: The 50 Most Influential Women in America," listed on Business Insider’s “Silicon Alley Top 100” and “36 Rockstar Women in NYC Tech," and Create + Cultivate’s 100 List for STEM.